MGTX
MeiraGTx Holdings plc
NASDAQ · USHealthcareBiotechnology
$12.21-1.85%
Price as of Jul 20, 2026
MGTX valuation
MeiraGTx Holdings plc valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 16.80x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -19.45x
- Price / sales
- 14.18x
- Price / cash flow
- 136.58x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 14.38x
- EV / EBITDA
- -11.98x
- EV / EBIT
- -10.90x
- Market cap
- $1.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.